Amarin Corp PLC (AMRN) stock
AMRNNasdaqPharmaceutical PreparationsFiscal year ends December 31
Financials through Q3 FY2026, quarter ended Sep 30, 2026Last filing: 10-Q on Oct 28, 2026Score 10/3061% above fair value
$11.27−0.04 (-0.35%)
Close on Nov 17, 2026Market cap $249.12MP/E –Yield –
Amarin price to sales ratio
The price-to-sales ratio is market cap divided by revenue over the trailing twelve months.
Amarin's price to sales ratio was 1.3× on Nov 11, 2026, against 1.5× a year earlier. Over the last 5 years it ranged from 0.8× to 2.4×, with a median of 1.3×.
Price to Sales Ratio at the end of each year
| Period | Period end | Value | Change (pts) |
|---|---|---|---|
| 2026 | Nov 11, 2026 | 1.3× | +0.0 |
| 2025 | Dec 31, 2025 | 1.3× | +0.5 |
| 2024 | Dec 31, 2024 | 0.8× | −0.3 |
| 2023 | Dec 29, 2023 | 1.1× | −0.1 |
| 2022 | Dec 30, 2022 | 1.2× | −1.0 |
| 2021 | Dec 31, 2021 | 2.2× | −1.0 |
| 2020 | Dec 31, 2020 | 3.2× | −17.8 |
| 2019 | Dec 31, 2019 | 21.1× | +1.0 |
| 2018 | Dec 31, 2018 | 20.1× | +13.6 |
| 2017 | Dec 29, 2017 | 6.5× | −0.5 |
| 2016 | Dec 30, 2016 | 7.0× | +2.2 |
| 2015 | Dec 31, 2015 | 4.8× | +1.3 |
| 2014 | Dec 31, 2014 | 3.6× | – |
See a number that looks wrong?